Please Wait
Applying Filters...
menu
    • menu
    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    Data Compilation
    #PharmaFlow

    Pipeline Prospector June 2025: Sanofi, AbbVie, Eli Lilly, BioNTech lead pharma M&A spree; BMS, Astra ink major collaborations

    Stock Recap
    #PipelineProspector

    Menu

    Northera

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    28/06/2025 Chongqing Shenghuaxi Pharma. Co., Ltd
    China
    		 Chongqing Shenghuaxi Pharmaceutical Co. ,Ltd 222MF10282 Droxidopa 2010-12-24 2010-12-24 No. 8 Jiangqiao Road, Nan an District Chongqing China
    28/06/2025 Chongqing Shenghuaxi Pharma. Co., Ltd
    China
    		 CHONGQING SHENGHUAXI PHARMACEUTICAL CO. , LTD. 218MF10680 Droxidopa 2006-08-11 2006-08-11 Renjiawan, Dashiba, Nan an Chongqing 40006, China